Recent advances in age-related metabolic dysfunction-associated steatotic liver disease

doi:10.3748/wjg.v30.i7.652

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2985)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

WORD

HTML

1846

Figures (1-2)

177

Sum=2105

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

109

Download

208

Sum=317

Publishing Process of This Article

Item

Count

Browse

116

Download

338

Sum=454

Feb 21, 2024 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Feb 21, 2024; 30(7): 652-662
Published online Feb 21, 2024. doi: 10.3748/wjg.v30.i7.652

Full Size Figure Download Figure

Figure 2 Targets related to lipids, bile acids, glucose homeostasis and intestinal microbiota in age-related metabolic dysfunction-associated steatotic liver disease. GM: Gut microbiota; FXR: Farnesoid X receptor; RXR: Retinoid X receptor; FXRE: FXR reaction element; FGF19: Fibroblast growth factor 19; FGFR4: Fibroblast growth factor receptor 4; TGR5: Takeda G protein–coupled receptor 5; GLP-1: Glucagon-like peptide-1.

Citation: He QJ, Li YF, Zhao LT, Lin CT, Yu CY, Wang D. Recent advances in age-related metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(7): 652-662
URL: https://www.wjgnet.com/1007-9327/full/v30/i7/652.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i7.652